Valuation: Getinge AB

Market Cap 56.08B 5.81B 5.09B 4.68B 4.35B 8.26B 554B 8.37B 21.83B 272B 21.81B 21.33B 943B P/E 2026 *
19.8x
P/E 2027 * 16.9x
Enterprise Value 64.74B 6.7B 5.87B 5.41B 5.02B 9.53B 640B 9.66B 25.19B 314B 25.18B 24.62B 1,088B EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.71x
Free-Float
78.61%
Yield 2026 *
2.45%
Yield 2027 * 2.69%
1 week+4.86%
Current month+3.84%
1 month+4.51%
3 months+5.04%
6 months-8.26%
Current year-7.81%
1 week 17.81
Extreme 17.81
18.92
1 month 17.05
Extreme 17.05
18.92
3 years 14.2
Extreme 14.2
21.19
5 years 14.2
Extreme 14.2
43.02
10 years 0
Extreme 0
43.02
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO - 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+4.86%+8.65%+24.44% 5.81B
-0.11%+0.88%+26.75%-4.03% 12.52B
-0.78%-2.55%+64.10%+36.01% 6.1B
-1.92%+2.76% - - 4.29B
-0.09%+1.76%-33.27%+9.48% 4.04B
-0.56%+0.95%-25.83%-23.58% 3.89B
+0.70%+11.89%-2.20%-57.20% 2.01B
+0.78%+5.22%+27.22%+257.14% 1.89B
-0.44%-0.64%+55.96%-6.87% 1.53B
+0.49%+4.53%-13.14%-45.23% 1.31B
Average -0.23%+4.23%+12.03%+21.13% 4.17B
Weighted average by Cap. -0.38%+2.67%+16.80%+14.33%

Financials

2026 *2027 *
Net sales 34.99B 3.62B 3.17B 2.92B 2.71B 5.15B 346B 5.22B 13.62B 170B 13.61B 13.31B 588B 36.79B 3.81B 3.34B 3.07B 2.85B 5.42B 363B 5.49B 14.32B 178B 14.31B 13.99B 619B
Net income 2.82B 292M 256M 235M 218M 415M 27.83B 420M 1.1B 13.66B 1.1B 1.07B 47.37B 3.3B 342M 299M 276M 256M 486M 32.58B 492M 1.28B 15.99B 1.28B 1.25B 55.45B
Net Debt 8.66B 896M 785M 723M 671M 1.27B 85.51B 1.29B 3.37B 41.97B 3.37B 3.29B 146B 6.66B 690M 604M 556M 517M 981M 65.81B 994M 2.59B 32.3B 2.59B 2.53B 112B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
-
Date Price Change
07/07/26 18.66 0.00%
06/07/26 €18.66 -1.24%
03/07/26 €18.90 +2.11%
02/07/26 €18.51 +1.23%
01/07/26 €18.28 +1.73%
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
205.90SEK
Average target price
226.70SEK
Spread / Average Target
+10.10%

Quarterly revenue - Rate of surprise